Home › Companies › COLLEGIUM PHARMACEUTICAL INC. › 2023-2024

COLLEGIUM PHARMACEUTICAL INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and COLLEGIUM PHARMACEUTICAL INC.’s Form 8-K, filed 2024-05-20 (Item 5.07 on EDGAR). Page generated 04 October 2026.

28Reported items
262Asset managers
3,186Fund votes
2024-05-16Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore COLLEGIUM PHARMACEUTICAL INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by COLLEGIUM PHARMACEUTICAL INC.

These tallies are COLLEGIUM PHARMACEUTICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-20 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

COLLEGIUM PHARMACEUTICAL INC. — official shareholder meeting results, meeting held 2024-05-16
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Rita Balice-Gordon	28,105,388	568,305	24,995	--	2,360,841	Majority: yes
Elect Director: Garen Bohlin	28,404,221	268,899	25,568	--	2,360,841	Majority: yes
Elect Director: John Fallon	25,399,411	3,273,949	25,328	--	2,360,841	Majority: yes
Elect Director: John Freund	28,384,244	289,466	24,978	--	2,360,841	Majority: yes
Elect Director: Michael Heffernan	26,121,329	2,552,363	24,996	--	2,360,841	Majority: yes
Elect Director: Neil McFarlane	28,442,938	230,764	24,986	--	2,360,841	Majority: yes
Elect Director: Gwen Melincoff	28,081,458	592,076	25,154	--	2,360,841	Majority: yes
Elect Director: Gino Santini	28,284,684	389,000	25,004	--	2,360,841	Majority: yes
Proposal 2: Approval of, on an advisory basis, the compensation of the Company's named executive officers.	28,311,783	350,755	36,150	--	2,360,841	Passed
Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.	30,106,217	92,255	23,996	--	837,061	Passed

Source: COLLEGIUM PHARMACEUTICAL INC., Form 8-K, filed with the SEC on 2024-05-20 — read the filing on EDGAR.

How asset managers voted at the COLLEGIUM PHARMACEUTICAL INC. 2023-2024 meeting

Each item below shows how the 262 asset managers that disclosed a COLLEGIUM PHARMACEUTICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of COLLEGIUM PHARMACEUTICAL INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval of, on an advisory basis, the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 10 wordings of this item as funds reported it.

99% Passed · of votes cast

FOR 99%

FOR: 28,311,783AGAINST: 350,755

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Proposal 2: Approval of, on an advisory basis, the compensation of the Company's named executive officers.”): 28,311,783 for, 350,755 against — passed, per its Form 8-K filed 2024-05-20 (Item 5.07). Of all 32,705,747 outstanding shares: 87% for, 1% against (88% of the company cast a for/against vote).

The 259 asset managers below cast 99.3% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 99.2%

FOR: 99.2%AGAINST: 0.7%ABSTAIN: 0.1%NOT VOTED: 0.0%

Largest asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Vote
BlackRock	3,446,901	For
MUTUAL FUND SERIES TRUST	2,629,593	For
Vanguard	2,330,784	For
Pacer Funds Trust	1,838,118	For
State Street	1,760,691	For
Invesco	1,723,974	For
Rubric Capital Management LP	1,286,955	For
PRINCIPAL GLOBAL INVESTORS	859,042	For
SEI	851,829	For
Camber Capital Management LP	842,125	For
FULLER & THALER ASSET MANAGEMENT, INC.	839,108	For
Capitol Series Trust	805,638	For
Victory Capital	801,488	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	661,798	For
Charles Schwab	643,641	For
Federated Hermes	635,203	For
Principal	623,061	For
MFS	563,156	For
Dimensional	543,891	For
EMERALD MUTUAL FUND ADVISERS TRUST	511,201	For
Janus Henderson	488,101	For
Rock Springs Capital Management LP	412,043	For
GEODE CAPITAL MANAGEMENT, LLC	369,386	For
Renaissance	359,653	For
Fidelity	344,105	For

Showing the 25 largest of 259 asset managers. See all 259 in the interactive database.

2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATEDCompany result: Passed

Combines 7 wordings of this item as funds reported it.

99.6% Passed · of votes cast

FOR 99.6%

FOR: 30,106,217AGAINST: 92,255

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Proposal 3: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 30,106,217 for, 92,255 against — passed, per its Form 8-K filed 2024-05-20 (Item 5.07). Of all 32,705,747 outstanding shares: 92% for, 0.3% against (92% of the company cast a for/against vote).

The 102 asset managers below cast 99.8% of the shares they voted on this item FOR (17,687,370 for, 28,573 against).

FOR 99.7%

FOR: 17,687,370 (99.8%)AGAINST: 28,573 (0.2%)ABSTAIN: 14,885 (0.1%)

Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accoun” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	2,629,593	0	For
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Pacer Funds Trust	1,838,118	0	For
Capitol Series Trust	805,638	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	538,553	48	For
Dimensional	475,900	0	For
SEI	421,512	0	For
Fidelity	342,492	0	For
Federated Hermes	316,301	0	For
Charles Schwab	313,530	0	For
Victory Capital	300,852	0	For
FINANCIAL INVESTORS TRUST	290,978	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	150,733	0	For
World Funds Trust	148,533	0	For
THIRD AVENUE TRUST	108,120	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

3. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 66 asset managers below cast 99.9% of the shares they voted on this item FOR (13,075,682 for, 8,840 against).

FOR: 13,075,682 (99.9%)AGAINST: 8,840 (0.1%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	2,629,593	0	For
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	538,442	159	For
Dimensional	475,900	0	For
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

4. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Garen Bohlin

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 65 asset managers below cast 99.9% of the shares they voted on this item FOR (10,454,832 for, 97 against).

FOR: 10,454,832 (100.0%)AGAINST: 97 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	538,504	97	For
Dimensional	475,900	0	For
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	48,800	0	For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

5. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gino Santini

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 65 asset managers below cast 99.9% of the shares they voted on this item FOR (10,453,075 for, 1,854 against).

FOR: 10,453,075 (100.0%)AGAINST: 1,854 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	538,456	145	For
Dimensional	475,900	0	For
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	48,800	0	For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

6. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gwen Melincoff

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 65 asset managers below cast 99.9% of the shares they voted on this item FOR (10,446,089 for, 8,840 against).

FOR: 10,446,089 (99.9%)AGAINST: 8,840 (0.1%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	538,442	159	For
Dimensional	475,900	0	For
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	48,800	0	For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

7. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Fallon M.D.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

93% fund support · no official result

FOR 93%

The 65 asset managers below cast 93% of the shares they voted on this item FOR (9,745,447 for, 709,482 against).

FOR: 9,745,447 (93.2%)AGAINST: 709,482 (6.8%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	909	537,692	Against
Dimensional	475,900	0	For
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	0	89,566	Against
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	48,800	0	For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

8. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Freund, M.D.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 65 asset managers below cast 99.9% of the shares they voted on this item FOR (10,454,832 for, 97 against).

FOR: 10,454,832 (100.0%)AGAINST: 97 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	538,504	97	For
Dimensional	475,900	0	For
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	48,800	0	For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

9. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Michael Heffernan, R.Ph.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

90% fund support · no official result

FOR 90%10%

The 65 asset managers below cast 90% of the shares they voted on this item FOR (9,408,443 for, 1,046,486 against).

FOR: 9,408,443 (90.0%)AGAINST: 1,046,486 (10.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	960	537,641	Against
Dimensional	0	475,900	Against
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	48,800	0	For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

10. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Neil F. Mcfarlane

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 65 asset managers below cast 99.9% of the shares they voted on this item FOR (10,454,832 for, 97 against).

FOR: 10,454,832 (100.0%)AGAINST: 97 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
BlackRock	2,531,055	0	For
Vanguard	2,240,414	0	For
Invesco	776,823	0	For
Principal	623,061	0	For
MFS	563,156	0	For
State Street	538,504	97	For
Dimensional	475,900	0	For
Fidelity	342,492	0	For
Victory Capital	300,852	0	For
Royce	284,976	0	For
JANUS INVESTMENT FUND	272,183	0	For
Prudential/PGIM	116,714	0	For
MassMutual	102,137	0	For
AllianceBernstein	94,740	0	For
MoA Funds Corp	92,802	0	For
Columbia Threadneedle	89,566	0	For
TIAA	87,848	0	For
American Century	86,862	0	For
Equitable	66,443	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,529	0	For
Pacific Life	61,565	0	For
WisdomTree	57,236	0	For
QUANTITATIVE MASTER SERIES LLC	53,301	0	For
BNY Mellon	49,889	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	48,800	0	For

Showing the 25 largest of 65 asset managers. See all 65 in the interactive database.

11. Election Of Director To Hold Office Until The 2025 Annual Meeting: Joseph Ciaffoni

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 76%ABSTAIN 24%

The 35 asset managers below cast 100% of the shares they voted on this item FOR (3,058,648 for, 0 against).

FOR: 3,058,648 (75.8%)ABSTAIN: 975,857 (24.2%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Joseph Ciaffoni” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Abstain	Vote
Pacer Funds Trust	1,838,118	0	For
SEI	0	421,512	Abstain
Federated Hermes	316,301	0	For
Charles Schwab	0	313,530	Abstain
FINANCIAL INVESTORS TRUST	290,978	0	For
Principal	151,414	0	For
World Funds Trust	148,533	0	For
THIRD AVENUE TRUST	108,120	0	For
Prudential/PGIM	102,828	0	For
Jackson National	0	80,085	Abstain
ADVISORS' INNER CIRCLE FUND	0	48,200	Abstain
JPMorgan	0	38,126	Abstain
Northern Lights Fund Trust IV	22,388	0	For
Allianz	0	20,786	Abstain
RBB Fund Trust	16,474	0	For
James Alpha Funds Trust	16,112	0	For
Global X	0	15,899	Abstain
Brighthouse	0	14,885	Abstain
Harbor ETF Trust	13,673	0	For
Russell Investments	12,905	0	For
John Hancock	0	12,372	Abstain
ETF Series Solutions	7,559	0	For
Bridge Builder Trust	0	5,924	Abstain
Investment Managers Series Trust II	5,445	0	For
NEW COVENANT FUNDS	0	2,915	Abstain

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

12. Election Of Director To Hold Office Until The 2025 Annual Meeting: John Freund, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 28,384,244AGAINST: 289,466

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: John Freund”): 28,384,244 for, 289,466 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 87% for, 0.9% against (88% of the company cast a for/against vote).

The 20 asset managers below cast 100% of the shares they voted on this item FOR (2,019,056 for, 0 against).

FOR 99.2%

FOR: 2,019,056 (99.3%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: John Freund, M.D.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Abstain	Vote
Capitol Series Trust	805,638	0	For
SEI	421,512	0	For
Federated Hermes	316,301	0	For
Charles Schwab	313,530	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
Prudential/PGIM	34,019	0	For
Empower	24,819	0	For
James Alpha Funds Trust	16,112	0	For
Global X	15,899	0	For
Brighthouse	0	14,885	Abstain
Russell Investments	12,905	0	For
NEW COVENANT FUNDS	2,915	0	For
TETON WESTWOOD FUNDS	2,700	0	For
Jackson Creek Investment Advisors LLC	1,432	0	For
Vericimetry Funds	1,110	0	For
SYNTAX ETF TRUST	937	0	For
Nationwide	536	0	For
Warren Street Wealth Advisors, LLC	255	0	For
CORNELL UNIVERSITY	202	0	For
Boltwood Capital Management	34	0	For

13. Election Of Director To Hold Office Until The 2025 Annual Meeting: Michael Heffernan, R.Ph.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 26,121,329AGAINST: 2,552,363

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Michael Heffernan”): 26,121,329 for, 2,552,363 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 80% for, 8% against (88% of the company cast a for/against vote).

The 20 asset managers below cast 97% of the shares they voted on this item FOR (1,960,218 for, 58,838 against).

FOR 96%

FOR: 1,960,218 (96.4%)AGAINST: 58,838 (2.9%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Michael Heffernan, R.Ph.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Capitol Series Trust	805,638	0	0	For
SEI	421,512	0	0	For
Federated Hermes	316,301	0	0	For
Charles Schwab	313,530	0	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	0	For
Prudential/PGIM	0	34,019	0	Against
Empower	0	24,819	0	Against
James Alpha Funds Trust	16,112	0	0	For
Global X	15,899	0	0	For
Brighthouse	0	0	14,885	Abstain
Russell Investments	12,905	0	0	For
NEW COVENANT FUNDS	2,915	0	0	For
TETON WESTWOOD FUNDS	2,700	0	0	For
Jackson Creek Investment Advisors LLC	1,432	0	0	For
Vericimetry Funds	1,110	0	0	For
SYNTAX ETF TRUST	937	0	0	For
Nationwide	536	0	0	For
Warren Street Wealth Advisors, LLC	255	0	0	For
CORNELL UNIVERSITY	202	0	0	For
Boltwood Capital Management	34	0	0	For

14. Election Of Director To Hold Office Until The 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 28,105,388AGAINST: 568,305

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Rita Balice-Gordon”): 28,105,388 for, 568,305 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 86% for, 2% against (88% of the company cast a for/against vote).

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,002,944 for, 0 against).

FOR 99.2%

FOR: 2,002,944 (99.3%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Abstain	Vote
Capitol Series Trust	805,638	0	For
SEI	421,512	0	For
Federated Hermes	316,301	0	For
Charles Schwab	313,530	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
Prudential/PGIM	34,019	0	For
Empower	24,819	0	For
Global X	15,899	0	For
Brighthouse	0	14,885	Abstain
Russell Investments	12,905	0	For
NEW COVENANT FUNDS	2,915	0	For
TETON WESTWOOD FUNDS	2,700	0	For
Jackson Creek Investment Advisors LLC	1,432	0	For
Vericimetry Funds	1,110	0	For
SYNTAX ETF TRUST	937	0	For
Nationwide	536	0	For
Warren Street Wealth Advisors, LLC	255	0	For
CORNELL UNIVERSITY	202	0	For
Boltwood Capital Management	34	0	For

15. Election Of Director To Hold Office Until The 2025 Annual Meeting: Garen Bohlin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%

FOR: 28,404,221AGAINST: 268,899

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Garen Bohlin”): 28,404,221 for, 268,899 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 87% for, 0.9% against (88% of the company cast a for/against vote).

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,017,946 for, 0 against).

FOR 99.2%

FOR: 2,017,946 (99.3%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Garen Bohlin” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Abstain	Vote
Capitol Series Trust	805,638	0	For
SEI	421,512	0	For
Federated Hermes	316,301	0	For
Charles Schwab	313,530	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
Prudential/PGIM	34,019	0	For
Empower	24,819	0	For
James Alpha Funds Trust	16,112	0	For
Global X	15,899	0	For
Brighthouse	0	14,885	Abstain
Russell Investments	12,905	0	For
NEW COVENANT FUNDS	2,915	0	For
TETON WESTWOOD FUNDS	2,700	0	For
Jackson Creek Investment Advisors LLC	1,432	0	For
SYNTAX ETF TRUST	937	0	For
Nationwide	536	0	For
Warren Street Wealth Advisors, LLC	255	0	For
CORNELL UNIVERSITY	202	0	For
Boltwood Capital Management	34	0	For

16. Election Of Director To Hold Office Until The 2025 Annual Meeting: Gino Santini

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 28,284,684AGAINST: 389,000

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Gino Santini”): 28,284,684 for, 389,000 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 86% for, 1% against (88% of the company cast a for/against vote).

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,017,946 for, 0 against).

FOR 99.2%

FOR: 2,017,946 (99.3%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Gino Santini” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Abstain	Vote
Capitol Series Trust	805,638	0	For
SEI	421,512	0	For
Federated Hermes	316,301	0	For
Charles Schwab	313,530	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
Prudential/PGIM	34,019	0	For
Empower	24,819	0	For
James Alpha Funds Trust	16,112	0	For
Global X	15,899	0	For
Brighthouse	0	14,885	Abstain
Russell Investments	12,905	0	For
NEW COVENANT FUNDS	2,915	0	For
TETON WESTWOOD FUNDS	2,700	0	For
Jackson Creek Investment Advisors LLC	1,432	0	For
SYNTAX ETF TRUST	937	0	For
Nationwide	536	0	For
Warren Street Wealth Advisors, LLC	255	0	For
CORNELL UNIVERSITY	202	0	For
Boltwood Capital Management	34	0	For

17. Election Of Director To Hold Office Until The 2025 Annual Meeting: Gwen Melincoff

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 28,081,458AGAINST: 592,076

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Gwen Melincoff”): 28,081,458 for, 592,076 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 86% for, 2% against (88% of the company cast a for/against vote).

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,017,946 for, 0 against).

FOR 99.2%

FOR: 2,017,946 (99.3%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Gwen Melincoff” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Abstain	Vote
Capitol Series Trust	805,638	0	For
SEI	421,512	0	For
Federated Hermes	316,301	0	For
Charles Schwab	313,530	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
Prudential/PGIM	34,019	0	For
Empower	24,819	0	For
James Alpha Funds Trust	16,112	0	For
Global X	15,899	0	For
Brighthouse	0	14,885	Abstain
Russell Investments	12,905	0	For
NEW COVENANT FUNDS	2,915	0	For
TETON WESTWOOD FUNDS	2,700	0	For
Jackson Creek Investment Advisors LLC	1,432	0	For
SYNTAX ETF TRUST	937	0	For
Nationwide	536	0	For
Warren Street Wealth Advisors, LLC	255	0	For
CORNELL UNIVERSITY	202	0	For
Boltwood Capital Management	34	0	For

18. Election Of Director To Hold Office Until The 2025 Annual Meeting: John Fallon M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 25,399,411AGAINST: 3,273,949

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: John Fallon”): 25,399,411 for, 3,273,949 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 78% for, 10% against (88% of the company cast a for/against vote).

The 19 asset managers below cast 75% of the shares they voted on this item FOR (1,504,601 for, 513,345 against).

FOR 74%AGAINST 25%

FOR: 1,504,601 (74.0%)AGAINST: 513,345 (25.3%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: John Fallon M.D.” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Capitol Series Trust	805,638	0	0	For
SEI	0	421,512	0	Against
Federated Hermes	316,301	0	0	For
Charles Schwab	313,530	0	0	For
ADVISORS' INNER CIRCLE FUND	0	48,200	0	Against
Prudential/PGIM	34,019	0	0	For
Empower	0	24,819	0	Against
James Alpha Funds Trust	16,112	0	0	For
Global X	0	15,899	0	Against
Brighthouse	0	0	14,885	Abstain
Russell Investments	12,905	0	0	For
NEW COVENANT FUNDS	0	2,915	0	Against
TETON WESTWOOD FUNDS	2,700	0	0	For
Jackson Creek Investment Advisors LLC	1,432	0	0	For
SYNTAX ETF TRUST	937	0	0	For
Nationwide	536	0	0	For
Warren Street Wealth Advisors, LLC	255	0	0	For
CORNELL UNIVERSITY	202	0	0	For
Boltwood Capital Management	34	0	0	For

19. Election Of Director To Hold Office Until The 2025 Annual Meeting: Neil F. Mcfarlane

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%

FOR: 28,442,938AGAINST: 230,764

COLLEGIUM PHARMACEUTICAL INC.’s own tally for this item (“Elect Director: Neil McFarlane”): 28,442,938 for, 230,764 against, per its Form 8-K filed 2024-05-20 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,705,747 outstanding shares: 87% for, 0.8% against (88% of the company cast a for/against vote).

The 19 asset managers below cast 99.2% of the shares they voted on this item FOR (2,001,834 for, 16,112 against).

FOR 98%

FOR: 2,001,834 (98.5%)AGAINST: 16,112 (0.8%)ABSTAIN: 14,885 (0.7%)

Largest asset managers voting on “Election Of Director To Hold Office Until The 2025 Annual Meeting: Neil F. Mcfarlane” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Capitol Series Trust	805,638	0	0	For
SEI	421,512	0	0	For
Federated Hermes	316,301	0	0	For
Charles Schwab	313,530	0	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	0	For
Prudential/PGIM	34,019	0	0	For
Empower	24,819	0	0	For
James Alpha Funds Trust	0	16,112	0	Against
Global X	15,899	0	0	For
Brighthouse	0	0	14,885	Abstain
Russell Investments	12,905	0	0	For
NEW COVENANT FUNDS	2,915	0	0	For
TETON WESTWOOD FUNDS	2,700	0	0	For
Jackson Creek Investment Advisors LLC	1,432	0	0	For
SYNTAX ETF TRUST	937	0	0	For
Nationwide	536	0	0	For
Warren Street Wealth Advisors, LLC	255	0	0	For
CORNELL UNIVERSITY	202	0	0	For
Boltwood Capital Management	34	0	0	For

20. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Garen Bohlin

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,612,365 for, 0 against).

FOR: 2,612,365 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Vote
Pacer Funds Trust	1,838,118	For
FINANCIAL INVESTORS TRUST	290,978	For
World Funds Trust	148,533	For
THIRD AVENUE TRUST	108,120	For
Jackson National	80,085	For
JPMorgan	38,126	For
Northern Lights Fund Trust IV	22,388	For
Allianz	20,786	For
RBB Fund Trust	16,474	For
Harbor ETF Trust	13,673	For
John Hancock	12,372	For
ETF Series Solutions	7,559	For
Bridge Builder Trust	5,924	For
Investment Managers Series Trust II	5,445	For
NORTHERN LIGHTS FUND TRUST II	2,651	For
WILSHIRE MUTUAL FUNDS INC	939	For
Managed Portfolio Series	104	For
CITY NATIONAL ROCHDALE FUNDS	46	For
GPS Funds I	44	For

21. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Gino Santini

DIRECTOR ELECTIONS

99.7% fund support · no official result

FOR 99.7%

The 19 asset managers below cast 99.7% of the shares they voted on this item FOR (2,604,806 for, 7,559 against).

FOR: 2,604,806 (99.7%)AGAINST: 7,559 (0.3%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
Pacer Funds Trust	1,838,118	0	For
FINANCIAL INVESTORS TRUST	290,978	0	For
World Funds Trust	148,533	0	For
THIRD AVENUE TRUST	108,120	0	For
Jackson National	80,085	0	For
JPMorgan	38,126	0	For
Northern Lights Fund Trust IV	22,388	0	For
Allianz	20,786	0	For
RBB Fund Trust	16,474	0	For
Harbor ETF Trust	13,673	0	For
John Hancock	12,372	0	For
ETF Series Solutions	0	7,559	Against
Bridge Builder Trust	5,924	0	For
Investment Managers Series Trust II	5,445	0	For
NORTHERN LIGHTS FUND TRUST II	2,651	0	For
WILSHIRE MUTUAL FUNDS INC	939	0	For
Managed Portfolio Series	104	0	For
CITY NATIONAL ROCHDALE FUNDS	46	0	For
GPS Funds I	44	0	For

22. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Gwen Melincoff

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,612,365 for, 0 against).

FOR: 2,612,365 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Vote
Pacer Funds Trust	1,838,118	For
FINANCIAL INVESTORS TRUST	290,978	For
World Funds Trust	148,533	For
THIRD AVENUE TRUST	108,120	For
Jackson National	80,085	For
JPMorgan	38,126	For
Northern Lights Fund Trust IV	22,388	For
Allianz	20,786	For
RBB Fund Trust	16,474	For
Harbor ETF Trust	13,673	For
John Hancock	12,372	For
ETF Series Solutions	7,559	For
Bridge Builder Trust	5,924	For
Investment Managers Series Trust II	5,445	For
NORTHERN LIGHTS FUND TRUST II	2,651	For
WILSHIRE MUTUAL FUNDS INC	939	For
Managed Portfolio Series	104	For
CITY NATIONAL ROCHDALE FUNDS	46	For
GPS Funds I	44	For

23. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting John Fallon

DIRECTOR ELECTIONS

99.1% fund support · no official result

FOR 99.1%

The 19 asset managers below cast 99.1% of the shares they voted on this item FOR (2,588,934 for, 23,431 against).

FOR: 2,588,934 (99.1%)AGAINST: 23,431 (0.9%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
Pacer Funds Trust	1,838,118	0	For
FINANCIAL INVESTORS TRUST	290,978	0	For
World Funds Trust	148,533	0	For
THIRD AVENUE TRUST	108,120	0	For
Jackson National	80,085	0	For
JPMorgan	38,126	0	For
Northern Lights Fund Trust IV	0	22,388	Against
Allianz	20,786	0	For
RBB Fund Trust	16,474	0	For
Harbor ETF Trust	13,673	0	For
John Hancock	12,372	0	For
ETF Series Solutions	7,559	0	For
Bridge Builder Trust	5,924	0	For
Investment Managers Series Trust II	5,445	0	For
NORTHERN LIGHTS FUND TRUST II	2,651	0	For
WILSHIRE MUTUAL FUNDS INC	0	939	Against
Managed Portfolio Series	0	104	Against
CITY NATIONAL ROCHDALE FUNDS	46	0	For
GPS Funds I	44	0	For

24. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting John Freund

DIRECTOR ELECTIONS

99.1% fund support · no official result

FOR 99.1%

The 19 asset managers below cast 99.1% of the shares they voted on this item FOR (2,589,977 for, 22,388 against).

FOR: 2,589,977 (99.1%)AGAINST: 22,388 (0.9%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
Pacer Funds Trust	1,838,118	0	For
FINANCIAL INVESTORS TRUST	290,978	0	For
World Funds Trust	148,533	0	For
THIRD AVENUE TRUST	108,120	0	For
Jackson National	80,085	0	For
JPMorgan	38,126	0	For
Northern Lights Fund Trust IV	0	22,388	Against
Allianz	20,786	0	For
RBB Fund Trust	16,474	0	For
Harbor ETF Trust	13,673	0	For
John Hancock	12,372	0	For
ETF Series Solutions	7,559	0	For
Bridge Builder Trust	5,924	0	For
Investment Managers Series Trust II	5,445	0	For
NORTHERN LIGHTS FUND TRUST II	2,651	0	For
WILSHIRE MUTUAL FUNDS INC	939	0	For
Managed Portfolio Series	104	0	For
CITY NATIONAL ROCHDALE FUNDS	46	0	For
GPS Funds I	44	0	For

25. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Michael Heffernan

DIRECTOR ELECTIONS

99.2% fund support · no official result

FOR 99.2%

The 19 asset managers below cast 99.2% of the shares they voted on this item FOR (2,591,495 for, 20,870 against).

FOR: 2,591,495 (99.2%)AGAINST: 20,870 (0.8%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Against	Vote
Pacer Funds Trust	1,838,118	0	For
FINANCIAL INVESTORS TRUST	290,978	0	For
World Funds Trust	148,533	0	For
THIRD AVENUE TRUST	108,120	0	For
Jackson National	71,084	9,001	For
JPMorgan	38,126	0	For
Northern Lights Fund Trust IV	22,388	0	For
Allianz	16,476	4,310	For
RBB Fund Trust	16,474	0	For
Harbor ETF Trust	13,673	0	For
John Hancock	12,372	0	For
ETF Series Solutions	0	7,559	Against
Bridge Builder Trust	5,924	0	For
Investment Managers Series Trust II	5,445	0	For
NORTHERN LIGHTS FUND TRUST II	2,651	0	For
WILSHIRE MUTUAL FUNDS INC	939	0	For
Managed Portfolio Series	104	0	For
CITY NATIONAL ROCHDALE FUNDS	46	0	For
GPS Funds I	44	0	For

26. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Neil F. Mcfarlane

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,612,365 for, 0 against).

FOR: 2,612,365 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Vote
Pacer Funds Trust	1,838,118	For
FINANCIAL INVESTORS TRUST	290,978	For
World Funds Trust	148,533	For
THIRD AVENUE TRUST	108,120	For
Jackson National	80,085	For
JPMorgan	38,126	For
Northern Lights Fund Trust IV	22,388	For
Allianz	20,786	For
RBB Fund Trust	16,474	For
Harbor ETF Trust	13,673	For
John Hancock	12,372	For
ETF Series Solutions	7,559	For
Bridge Builder Trust	5,924	For
Investment Managers Series Trust II	5,445	For
NORTHERN LIGHTS FUND TRUST II	2,651	For
WILSHIRE MUTUAL FUNDS INC	939	For
Managed Portfolio Series	104	For
CITY NATIONAL ROCHDALE FUNDS	46	For
GPS Funds I	44	For

27. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Rita Balice- Gordon

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 19 asset managers below cast 100% of the shares they voted on this item FOR (2,612,365 for, 0 against).

FOR: 2,612,365 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Vote
Pacer Funds Trust	1,838,118	For
FINANCIAL INVESTORS TRUST	290,978	For
World Funds Trust	148,533	For
THIRD AVENUE TRUST	108,120	For
Jackson National	80,085	For
JPMorgan	38,126	For
Northern Lights Fund Trust IV	22,388	For
Allianz	20,786	For
RBB Fund Trust	16,474	For
Harbor ETF Trust	13,673	For
John Hancock	12,372	For
ETF Series Solutions	7,559	For
Bridge Builder Trust	5,924	For
Investment Managers Series Trust II	5,445	For
NORTHERN LIGHTS FUND TRUST II	2,651	For
WILSHIRE MUTUAL FUNDS INC	939	For
Managed Portfolio Series	104	For
CITY NATIONAL ROCHDALE FUNDS	46	For
GPS Funds I	44	For

28. Elect Director Joseph Ciaffoni Withdrawn Resolution

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

UNKNOWN 97%

The 12 asset managers below cast 100% of the shares they voted on this item FOR (255 for, 0 against).

FOR: 255 (0.0%)ABSTAIN: 20,966 (1.0%)UNKNOWN: 2,093,610 (96.8%)N/A: 24,819 (1.1%)NOT VOTED: 18,561 (0.9%)NON-VOTING BALLOT: 4,300 (0.2%)NAN: 202 (0.0%)

Largest asset managers voting on “Elect Director Joseph Ciaffoni *Withdrawn Resolution*” at COLLEGIUM PHARMACEUTICAL INC., 2023-2024
Asset manager	For	Abstain	Vote
MUTUAL FUND SERIES TRUST	0	0	Unknown
Capitol Series Trust	0	0	Unknown
Empower	0	0	N/A
Catholic Responsible Investments Funds	0	20,966	Abstain
Lincoln Financial	0	0	Not Voted
Blackstone Alternative Investment Funds	0	0	Non-Voting Ballot
SA FUNDS INVESTMENT TRUST	0	0	Unknown
Keel Point, LLC	0	0	Not Voted
Warren Street Wealth Advisors, LLC	255	0	For
CORNELL UNIVERSITY	0	0	Nan
Humankind Benefit Corp	0	0	Unknown
WisdomTree	0	0	--

Largest COLLEGIUM PHARMACEUTICAL INC. shareholders voting in 2023-2024

Ranked by the number of COLLEGIUM PHARMACEUTICAL INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 32,705,747 shares outstanding at the time of that meeting.

Top COLLEGIUM PHARMACEUTICAL INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	BlackRock	10.54%
2	MUTUAL FUND SERIES TRUST	8.04%
3	Vanguard	7.13%
4	Pacer Funds Trust	5.62%
5	State Street	5.38%
6	Invesco	5.27%
7	Rubric Capital Management LP	3.93%
8	PRINCIPAL GLOBAL INVESTORS	2.63%
9	SEI	2.60%
10	Camber Capital Management LP	2.57%

Reported COLLEGIUM PHARMACEUTICAL INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

COLLEGIUM PHARMACEUTICAL INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.83%	13F
Rubric Capital Management LP	8.43%	DEF14A
Eventide Asset Management, LLC	8.04%	DEF14A
Vanguard Group	6.81%	13F
Principal Global Investors, LLC	5.34%	13G
Invesco	4.99%	13F
Renaissance Technologies	4.34%	13F
State Street	4.03%	13F
Dimensional Fund Advisors	3.12%	13F
Goldman Sachs	2.45%	13F

Percentages above are of 32,705,747 shares outstanding, as reported by COLLEGIUM PHARMACEUTICAL INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COLLEGIUM PHARMACEUTICAL INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At COLLEGIUM PHARMACEUTICAL INC.'s shareholder meeting held 2024-05-16, in the 2023-2024 proxy season, 262 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,186 separate fund positions. Their filings are grouped here into 28 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval of, on an advisory basis, the compensation of the Company's named executive officers. — the proposal passed with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: COLLEGIUM PHARMACEUTICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-20.

COLLEGIUM PHARMACEUTICAL INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

COLLEGIUM PHARMACEUTICAL INC. 2023-2024 Proxy Voting Records

Official 2023-2024 meeting results reported by COLLEGIUM PHARMACEUTICAL INC.

How asset managers voted at the COLLEGIUM PHARMACEUTICAL INC. 2023-2024 meeting

1. Approval of, on an advisory basis, the compensation of the Company's named executive officers.

2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

3. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.

4. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Garen Bohlin

5. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gino Santini

6. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Gwen Melincoff

7. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Fallon M.D.

8. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: John Freund, M.D.

9. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Michael Heffernan, R.Ph.

10. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F. Mcfarlane, Joseph Ciaffoni, Michael Heffernan, R.Ph. and Gino Santini as directors to hold office until the 2025 Annual Meeting: Neil F. Mcfarlane

11. Election Of Director To Hold Office Until The 2025 Annual Meeting: Joseph Ciaffoni

12. Election Of Director To Hold Office Until The 2025 Annual Meeting: John Freund, M.D.

13. Election Of Director To Hold Office Until The 2025 Annual Meeting: Michael Heffernan, R.Ph.

14. Election Of Director To Hold Office Until The 2025 Annual Meeting: Rita Balice-Gordon, Ph.D.

15. Election Of Director To Hold Office Until The 2025 Annual Meeting: Garen Bohlin

16. Election Of Director To Hold Office Until The 2025 Annual Meeting: Gino Santini

17. Election Of Director To Hold Office Until The 2025 Annual Meeting: Gwen Melincoff

18. Election Of Director To Hold Office Until The 2025 Annual Meeting: John Fallon M.D.

19. Election Of Director To Hold Office Until The 2025 Annual Meeting: Neil F. Mcfarlane

20. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Garen Bohlin

21. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Gino Santini

22. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Gwen Melincoff

23. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting John Fallon

24. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting John Freund

25. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Michael Heffernan

26. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Neil F. Mcfarlane

27. Election of Rita Balice-Gordon, Ph.D., Garen Bahlin, Gwen Melincoff, John Fallon M.D., John Freund, M.D., Neil F.Mcfarlane, Joseph Ciaffoni, Michael Heffernan,R.Ph. and Gino Santini as directors to hold office until the 2025 Annual meeting Rita Balice- Gordon

28. Elect Director Joseph Ciaffoni *Withdrawn Resolution*

Largest COLLEGIUM PHARMACEUTICAL INC. shareholders voting in 2023-2024

Reported COLLEGIUM PHARMACEUTICAL INC. ownership

About this page

28. Elect Director Joseph Ciaffoni Withdrawn Resolution